As previously mentioned, the relationships of YBX3 expression levels with tumor staging, metastasis, tumor microenvironment, immune evasion, and chemotherapeutic drug sensitivity across 39 TCGA cancer types and subtypes were further investigated. Here, YBX3 is linked to neoplasm.